LTA and cancer: Given the contribution of APOBEC3s in genomic cancer mutations and viral mutations in antiviral defense, our findings strongly suggest that APOBEC3 subfamily, particularly APOBEC3A, APOBEC3H, APOBEC3C, and to smaller extent APOBEC3G, contribute to the LT mutation signature and potentially premature stop codon formation.